Management of Paclitaxel Allergic Reactions

Immediate Recognition and Acute Management

The American Society of Clinical Oncology recommends stopping or slowing the infusion rate and administering symptomatic treatment with antihistamines and corticosteroids for mild to moderate reactions (Grade 1-2) 1, 2, 3
For severe reactions (Grade 3-4), the National Comprehensive Cancer Network recommends permanently stopping the infusion, administering intramuscular epinephrine, and considering desensitization protocols if paclitaxel remains the preferred therapy 1, 2, 3
The infusion can be restarted at a much slower rate (typically 50% of original rate) if symptoms resolve and the patient, physician, and nursing staff are all comfortable proceeding 4, 6
Emergency equipment must be immediately available in the treatment area 4, 6

The American College of Physicians recommends that all patients receive premedication before paclitaxel administration to reduce severe reactions from 30% to 2-4% 1, 2
Dexamethasone, diphenhydramine, and H2 receptor antagonist should be administered 30 minutes before paclitaxel infusion 1, 2, 3

Paclitaxel reactions occur within the first 10 minutes of infusion, typically during the first or second dose 1, 8, 2, 3
Reactions occur in up to 30% of patients without premedication, but only 2-4% with proper premedication 1, 2, 3

The National Comprehensive Cancer Network recommends desensitization as the only safe method to continue paclitaxel if it remains the preferred therapy after a severe hypersensitivity reaction 4, 2, 7, 6
Desensitization must be performed with each subsequent infusion, as it does not provide lasting tolerance 7

Cross-reactivity between paclitaxel and docetaxel ranges from 50-90% in the literature, though unpublished clinical experience suggests lower rates 8
Nab-paclitaxel (albumin-bound paclitaxel) is well tolerated in patients with paclitaxel and docetaxel allergy because it lacks the kolliphor EL diluent 8

Never delay epinephrine administration in suspected anaphylaxis; it is the first-line treatment and should be given intramuscularly immediately 5
Premedication with corticosteroids and antihistamines does not prevent recurrent severe reactions in sensitized patients; desensitization is required 4, 2
Standing orders for emergency intervention must be written before each infusion, and emergency equipment must be immediately available 4, 6